✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Laurus Labs Ltd.

LAURUSLABS

Market Cap
₹35,800 Cr.
P/E
99.91

Laurus Labs Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
35,800 Cr
PE
PE
99.91
Prom Holding
Prom Holding
27.62 %
ROE (%)
ROE (%)
8.01
ROCE (%)
ROCE (%)
12.08
Div Yield (%)
Div Yield (%)
0.18
Sales
Sales
5,553 Cr
OPM (%)
OPM (%)
19.00 %
Debt to Equity
Debt to Equity
0.61
View more
Edit Ratio's
About
Laurus Labs Limited is a leading player in the global pharmaceutical industry, offering a wide… Read more
Low
414
52W Range
High
683
  • Laurus Labs
  • Neuland Laboratories
  • Alivus Life Sciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

API Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Number of ANDA's Approved by Canada
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Neogen Chemicals Ltd.
    • HLE Glascoat Ltd.
    • Tatva Chintan Pharma Chem Ltd.
    • Chemcon Speciality Chemicals Ltd.
    Customers
    • Aurobindo Pharma Ltd.
    • Cipla Ltd.
    • Natco Pharma Ltd.
    • Strides Pharma Science Ltd.
    • Sun Pharmaceutical Industries Ltd.
    FAQs on Laurus Labs Ltd. Business

    Laurus Labs Limited offers a wide range of Active Pharma Ingredients (API), Generic Finished dosage forms (FDF), and Contract Research services globally, focusing on areas like anti-retroviral, Hepatitis C, and Oncology drugs through continuous innovation.

    Laurus Labs major competitors are Neuland Laboratories, Alivus Life Sciences, Granules India, Shilpa Medicare, Acutaas Chemicals, Aarti Pharmalabs, Supriya Lifescience.
    Market Cap of Laurus Labs is ₹35,800 Crs.
    While the median market cap of its peers are ₹9,061 Crs.

    Laurus Labs seems to be less financially stable compared to its competitors.
    Altman Z score of Laurus Labs is 5.96 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Laurus Labs Ltd.
    Divis vs Laurus - SOIC
    Why LaurusLabs bought a significant stake in a cell and gene therapy startup ImmunoACT? - Tar
    Laurus | An Emerging Moat? - SOIC
    View the discussion on ValuePickr
    What’s up with Laurus Labs? - StockEdge
    Approval of First Long Acting Injectable HIV Treatment on Laurus Labs - Dr Midhun
    Some Red Flags For Laurus Labs - Deepak Kapur
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material